Zobrazeno 1 - 5
of 5
pro vyhledávání: '"551"'
Autor:
Yun Fa Lai, Cheng Hung Lee, Ching Hsiung Lin, Jeng Yuan Hsu, Liang Wen Hang, Jia Horng Wang, Shih Feng Liu, Yu Chih Liu, Shih Lung Cheng, Hao-Chien Wang, Ming Shyang Huang, Ming Lin Ho, Kuang Yao Yang
Publikováno v:
Drug Design, Development and Therapy. 14:5441-5450
Introduction In the prospective, observational, 16-week REACT study conducted between October 21, 2008 and May 12, 2011, we compared the real-world effectiveness of anti-inflammatory reliever and maintenance therapy with budesonide/formoterol (Symbic
Publikováno v:
Neuropsychiatric Disease and Treatment
Yang Liu,1,2,* Jun Liang,2,* Qingrong Xia,2 Xin Zhou,1 Xuefeng Xie1 1Department of Basic and Clinical Pharmacology, Anhui Institute of Innovative Drugs, School of Pharmacy, Anhui Medical University, Hefei 230032, Anhui, People’s Republic of China;
Autor:
Regina Schinner, Tim A. Labeur, Heinz-Josef Klümpen, Ron A. A. Mathôt, Peter Malfertheiner, Jens Ricke, Otto M. van Delden, Julia Mayerle, Holger Amthauer, Kerstin Schütte, Bristi Basu, R. Bart Takkenberg, Quincy Hofsink, Christiane K. Kuhl
Publikováno v:
Acta Oncologica, 59(9), 1028-1035. Informa Healthcare
Background: Sorafenib for advanced hepatocellular carcinoma (HCC) is dose adjusted by toxicity. Preliminary studies have suggested an association between plasma concentrations of sorafenib and its main metabolite (M2) and clinical outcomes. This stud
Autor:
Francisco Vera-Médez, Belén Vendrell, Jose-Antonio Pérez-Molina, Jesús Santos, Oscar Serrano, Ana Moreno, José M. Gatell, Bonaventura Clotet, Juan Flores, María J Pérez-Elías
Publikováno v:
HIV Clinical Trials. 10:269-275
To describe the short-term, liver safety, immunological, and virological outcome in HIV subjects according to their hepatitis co-infection status after switching to ritonavir-boosted atazanavir (ATV/r)-based therapy.Rates of treatment discontinuation
Autor:
Patience O. Obih, Adebayo Oyekan
Publikováno v:
Blood Pressure. 17:55-63
This study evaluated the role of PPARalpha in renal function and whether PPARalpha knockout (KO) mice are hypertensive or salt-sensitive. We hypothesize that PPARalpha modulation of ion transport defines the capacity for sodium excretion (U(Na)V). PP